Cargando…

EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis

Detalles Bibliográficos
Autores principales:	Hatziagorou, E., Peftoulidou, P., Toulia, I., Tasika, E., Chrysochoou, E.-A., Tsanakas, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	ePoster Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192145/ http://dx.doi.org/10.1016/S1569-1993(21)01001-8

Ejemplares similares

ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis
por: Chrysochoou, E.-A., et al.
Publicado: (2022)

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021)

EP03 Parechovirus in a pathologist
por: Masih, Claire, et al.
Publicado: (2020)

EPS1.01 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic
por: Mittaine, M., et al.
Publicado: (2021)

EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis
por: Johnstone, Z., et al.
Publicado: (2021)

EPS1.05 Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis
por: Daniels, T., et al.
Publicado: (2021)

EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
por: Brown, C., et al.
Publicado: (2021)

EPS2.07 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland?
por: Mielus, M., et al.
Publicado: (2021)

EPS1.06 A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre
por: Waller, I., et al.
Publicado: (2021)

EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK
por: Connolly, A., et al.
Publicado: (2021)

Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing
por: Hatziagorou, Elpis, et al.
Publicado: (2021)

EPS1.09 Adapting services during the COVID-19 pandemic – a patient evaluation of physiotherapy telephone reviews within multidisciplinary team virtual clinics
por: Fitzgerald, S., et al.
Publicado: (2021)

EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2
por: Schwarz, C., et al.
Publicado: (2021)

ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT)
por: Braisdell, K., et al.
Publicado: (2022)

P224 Change in care during the COVID-19 pandemic: single-centre experience in a middle-income setting
por: Hatziagorou, E., et al.
Publicado: (2021)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

EP20 Hypercalcaemia in sarcoidosis
por: Chopra, Tanya, et al.
Publicado: (2020)

EP17 Finding the road to sarcoidosis
por: Nizam, Sharmin
Publicado: (2020)

EP33 Sjögren’s and lymphoproliferative disorders
por: Yein, Khin, et al.
Publicado: (2020)

EP27 Sjögren’s or not: an anxious diagnosis
por: Nizam, Sharmin
Publicado: (2020)

EP32 Gastroparesis in Sjögren’s syndrome
por: Saulite, Vera, et al.
Publicado: (2020)

EP14 COVID-19 associated aortitis
por: Zou, Yun, et al.
Publicado: (2020)

EP18 Testicular sarcoidosis: a challenging diagnosis
por: Patel, Vishit, et al.
Publicado: (2020)

EP04 Is this scleroderma lung or COVID-19 lung?
por: Malik, Dr Saadia, et al.
Publicado: (2020)

EP25 Blau syndrome: a lifetime of sarcoid
por: Chauhan, Neal, et al.
Publicado: (2020)

EP01 Post COVID-19 reactive arthritis
por: Waller, Rosemary, et al.
Publicado: (2020)

EP06 COVID-19 masquerading as myositis and myopericarditis
por: Siosi, Alexa José Escudero, et al.
Publicado: (2020)

EP35 Cryoglobulinaemic vasculitis: an uncommon complication of Sjögren’s syndrome
por: Chen-Xu, Michael, et al.
Publicado: (2020)

EP12 Chikungunga arthritis mimicking acute seronegative spondyloarthritis
por: Arora, Palak, et al.
Publicado: (2020)

EP26 HIV infection masquerading as connective tissue disease
por: Javaid, Zeeshan, et al.
Publicado: (2020)

EP28 A case of ANCA vasculitis presenting with Sjögren’s serology
por: Ayub, Shazeen, et al.
Publicado: (2020)

EP24 Arthritis mutilans coexisting with three separate granulomatous diseases
por: Saito, Ritsuko, et al.
Publicado: (2020)

EP10 Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19
por: Ong, Melissa, et al.
Publicado: (2020)

EP36 Caecal vasculitis: a rare and dangerous complication of Sjögren’s syndrome
por: Ellis, Jessica, et al.
Publicado: (2020)

EP22 A manifestation of severe sarcoid arthropathy in the distal interphalangeal joint
por: Ark, Rajiv
Publicado: (2020)

EP02 A rare case of Reactive arthritis secondary to COVID-19
por: Sidhu, Arslan, et al.
Publicado: (2020)

EP30 Sensory ganglionopathy as a possible presenting feature of Sjögren’s syndrome
por: Ummur, Preeya, et al.
Publicado: (2020)

EP15 A self-limiting symmetrical polyarthritis following COVID-19 infection
por: Gibson, Mark, et al.
Publicado: (2020)

EP23 Symptomatic sarcoid myopathy: a rare extra-pulmonary manifestation of sarcoidosis
por: Ali, Saadia Sasha, et al.
Publicado: (2020)

EP11 A case of COVID-19 induced myocarditis in a healthcare-worker
por: El-Ghazali, Shawki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u1e5tao2sru85soor5o3pauo7f